Dosing Woes For VBI Vaccines As Share Price Plummets On Hep B Study Results

 
• By Jo Shorthouse
  
Arch_Hands
The PROTECT study tested Sci-B-Vac against GSK's Engerix-B • Source: Shutterstock

More from Anti-infective

More from Therapy Areas